242 Phase I study of irinotecan (I), raltitrexed (R), and 5-fluorouracil (5FU) in the treatment of metastatic colorectal cancer (MCRC) refractory to thymidylate synthase inhibitors (TSI)Rakesh Goel, Leslie Douglas, C. Cripps et al.|European Journal of Cancer Supplements|2003Cited by 0